Urticaria
Conference Coverage
Choose your steps for treating chronic spontaneous urticaria
CAYMAN ISLANDS – U.S. and European guidelines start with high-dose second-generation antihistamines, but differ in when to introduce other drugs...
Environmental Dermatology
What’s Eating You? Bedbugs
Bedbugs are an increasing problem in the workplace. Employees must be educated on the signs of a bedbug infestation and take preventive measures...
Case Reports
Ice Pack–Induced Perniosis: A Rare and Underrecognized Association
Perniosis, or chilblain, is characterized by skin lesions that occur as an abnormal reaction to exposure to cold and damp conditions. Ice pack–...
Case Letter
Gemcitabine-Induced Pseudocellulitis
Gemcitabine-induced pseudocellulitis is a rare cutaneous side effect of gemcitabine therapy. Early recognition of pseudocellulitis may prevent...
Conference Coverage
Ligelizumab outperformed omalizumab for refractory chronic spontaneous urticaria
PARIS – Investigational drug ligelizumab achieved a faster response, higher clearance rate in a phase 2b study.
Case Letter
Autoimmune Progesterone Dermatitis
Case Reports
Metastatic Vulvovaginal Crohn Disease in the Setting of Well-Controlled Intestinal Disease
The cutaneous manifestations of Crohn disease (CD) are varied and include pyoderma gangrenosum, erythema nodosum, and metastatic CD (MCD). The...
Case Reports
Eosinophilic Pustular Folliculitis With Underlying Mantle Cell Lymphoma
Eosinophilic pustular folliculitis (EPF) is a noninfectious condition characterized by folliculocentric papules, pustules, and plaques on the head...
Case Reports
Acrodermatitis Enteropathica From Zinc-Deficient Total Parenteral Nutrition
Acrodermatitis enteropathica (AE) is a rare autosomal-recessive disorder of zinc malabsorption, characterized by acral and periorificial...
Conference Coverage
Teleconference is effective in assessing penicillin allergy
ORLANDO - Teleconferencing saved money, physician time, and patient exposure to more potent antibiotics.
Latest News
Omalizumab for chronic urticaria quells suffocation fears
GENEVA – The X-ACT study spotlights profound quality-of-life impairment in patients with chronic spontaneous urticaria.